Fabiflu 400mg

Antiviral

Description
Shipping Options
Customer Reviews

1. Product Description

Brand Name: Fabiflu 400mg Generic Name: Favipiravir Manufacturer: Glenmark Pharmaceuticals (India) Dosage Form: Film-coated tablets Packaging: Blister strips (varies by pack size) Approval Status: Emergency use authorization for COVID-19 in India

2. Composition

Component	Details
Active Ingredient	Favipiravir 400mg
Inactive Ingredients	Microcrystalline cellulose, Povidone, Croscarmellose sodium, Magnesium stearate, Film coating agents

3. Therapeutic Uses

Primary Indication:

Treatment of mild to moderate COVID-19 in adults (as per emergency approvals)

Mechanism of Action:

Inhibits RNA-dependent RNA polymerase (RdRp), blocking viral replication of SARS-CoV-2 and other RNA viruses.

Recommended For:

Patients with SpO₂ ≥ 94% (not for severe/critical COVID-19)
Early-stage infection (within 3-5 days of symptom onset)

4. Dosage & Administration

Standard COVID-19 Treatment Course:

Day 1 (Loading Dose): 1800mg (4.5 tablets of 400mg) twice daily
Days 2-10 (Maintenance): 800mg (2 tablets of 400mg) twice daily
Total Duration: 10-14 days (or as prescribed)

Administration Guidelines: ✔ Swallow whole with water (do not crush/chew) ✔ Can be taken with or without food ✔ Maintain consistent 12-hour intervals between doses

5. Contraindications

❌ Pregnancy (teratogenic risk – causes fetal abnormalities) ❌ Severe liver/kidney impairment ❌ History of gout or hyperuricemia (may increase uric acid) ❌ Hypersensitivity to favipiravir

6. Side Effects

Common	Less Common	Serious (Seek Medical Help)
Nausea	Diarrhea	Severe liver damage (jaundice)
Headache	Elevated uric acid	Allergic reactions (rash, swelling)
Stomach pain	Increased ALT/AST (LFT abnormalities)	Neuropsychiatric symptoms (hallucinations)

7. Storage Conditions

Temperature: Below 30°C
Humidity: Keep in a dry place
Packaging: Retain in original blister strips until use
Shelf Life: Typically 24 months (check packaging)

Disposal:

Do not flush. Return unused tablets to pharmacies for safe disposal.

8. Drug Interactions

⚠ Pyrazinamide/Theophylline: May alter drug levels ⚠ Repaglinide: Potential hypoglycemia risk ⚠ Alcohol: May worsen liver effects

9. Special Precautions

Pregnancy Test Required before prescribing to women of childbearing age.
Contraception Mandatory during and 1 week post-treatment.
Monitoring Needed:
- Liver function tests (LFTs)
- Uric acid levels
- Clinical symptom progression

10. Manufacturer & Regulatory Notes

Approved Under: Emergency use in India, Russia, Japan (as Avigan)
Not FDA-Approved for COVID-19 in the USA
Prescription-Only – Self-medication is unsafe.

Key Takeaways

Fabiflu 400mg is an antiviral for early COVID-19 management.
Strictly avoid in pregnancy (risk category: X).
Early initiation (within 72 hours of symptoms) improves outcomes.

1. Product Description

Brand Name: Fabiflu 400mg
Generic Name: Favipiravir
Manufacturer: Glenmark Pharmaceuticals (India)
Dosage Form: Film-coated tablets
Packaging: Blister strips (varies by pack size)
Approval Status: Emergency use authorization for COVID-19 in India

2. Composition

Component	Details
Active Ingredient	Favipiravir 400mg
Inactive Ingredients	Microcrystalline cellulose, Povidone, Croscarmellose sodium, Magnesium stearate, Film coating agents

3. Therapeutic Uses

Primary Indication:

Treatment of mild to moderate COVID-19 in adults (as per emergency approvals)

Mechanism of Action:

Inhibits RNA-dependent RNA polymerase (RdRp), blocking viral replication of SARS-CoV-2 and other RNA viruses.

Recommended For:

Patients with SpO₂ ≥ 94% (not for severe/critical COVID-19)
Early-stage infection (within 3-5 days of symptom onset)

4. Dosage & Administration

Standard COVID-19 Treatment Course:

Day 1 (Loading Dose): 1800mg (4.5 tablets of 400mg) twice daily
Days 2-10 (Maintenance): 800mg (2 tablets of 400mg) twice daily
Total Duration: 10-14 days (or as prescribed)

Administration Guidelines:
✔ Swallow whole with water (do not crush/chew)
✔ Can be taken with or without food
✔ Maintain consistent 12-hour intervals between doses

5. Contraindications

❌ Pregnancy (teratogenic risk – causes fetal abnormalities)
❌ Severe liver/kidney impairment
❌ History of gout or hyperuricemia (may increase uric acid)
❌ Hypersensitivity to favipiravir

6. Side Effects

Common	Less Common	Serious (Seek Medical Help)
Nausea	Diarrhea	Severe liver damage (jaundice)
Headache	Elevated uric acid	Allergic reactions (rash, swelling)
Stomach pain	Increased ALT/AST (LFT abnormalities)	Neuropsychiatric symptoms (hallucinations)

7. Storage Conditions

Temperature: Below 30°C
Humidity: Keep in a dry place
Packaging: Retain in original blister strips until use
Shelf Life: Typically 24 months (check packaging)

Disposal:

Do not flush. Return unused tablets to pharmacies for safe disposal.

8. Drug Interactions

⚠ Pyrazinamide/Theophylline: May alter drug levels
⚠ Repaglinide: Potential hypoglycemia risk
⚠ Alcohol: May worsen liver effects

9. Special Precautions

Pregnancy Test Required before prescribing to women of childbearing age.
Contraception Mandatory during and 1 week post-treatment.
Monitoring Needed:
- Liver function tests (LFTs)
- Uric acid levels
- Clinical symptom progression

10. Manufacturer & Regulatory Notes

Approved Under: Emergency use in India, Russia, Japan (as Avigan)
Not FDA-Approved for COVID-19 in the USA
Prescription-Only – Self-medication is unsafe.

Key Takeaways

Fabiflu 400mg is an antiviral for early COVID-19 management.
Strictly avoid in pregnancy (risk category: X).
Early initiation (within 72 hours of symptoms) improves outcomes.

Shipping Options –

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions –

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

Description
Reviews (0)

1. Product Description

Brand Name: Fabiflu 400mg
Generic Name: Favipiravir
Manufacturer: Glenmark Pharmaceuticals (India)
Dosage Form: Film-coated tablets
Packaging: Blister strips (varies by pack size)
Approval Status: Emergency use authorization for COVID-19 in India

2. Composition

Component	Details
Active Ingredient	Favipiravir 400mg
Inactive Ingredients	Microcrystalline cellulose, Povidone, Croscarmellose sodium, Magnesium stearate, Film coating agents

3. Therapeutic Uses

Primary Indication:

Treatment of mild to moderate COVID-19 in adults (as per emergency approvals)

Mechanism of Action:

Inhibits RNA-dependent RNA polymerase (RdRp), blocking viral replication of SARS-CoV-2 and other RNA viruses.

Recommended For:

Patients with SpO₂ ≥ 94% (not for severe/critical COVID-19)
Early-stage infection (within 3-5 days of symptom onset)

4. Dosage & Administration

Standard COVID-19 Treatment Course:

Day 1 (Loading Dose): 1800mg (4.5 tablets of 400mg) twice daily
Days 2-10 (Maintenance): 800mg (2 tablets of 400mg) twice daily
Total Duration: 10-14 days (or as prescribed)

Administration Guidelines:
✔ Swallow whole with water (do not crush/chew)
✔ Can be taken with or without food
✔ Maintain consistent 12-hour intervals between doses

5. Contraindications

❌ Pregnancy (teratogenic risk – causes fetal abnormalities)
❌ Severe liver/kidney impairment
❌ History of gout or hyperuricemia (may increase uric acid)
❌ Hypersensitivity to favipiravir

6. Side Effects

Common	Less Common	Serious (Seek Medical Help)
Nausea	Diarrhea	Severe liver damage (jaundice)
Headache	Elevated uric acid	Allergic reactions (rash, swelling)
Stomach pain	Increased ALT/AST (LFT abnormalities)	Neuropsychiatric symptoms (hallucinations)

7. Storage Conditions

Temperature: Below 30°C
Humidity: Keep in a dry place
Packaging: Retain in original blister strips until use
Shelf Life: Typically 24 months (check packaging)

Disposal:

Do not flush. Return unused tablets to pharmacies for safe disposal.

8. Drug Interactions

⚠ Pyrazinamide/Theophylline: May alter drug levels
⚠ Repaglinide: Potential hypoglycemia risk
⚠ Alcohol: May worsen liver effects

9. Special Precautions

Pregnancy Test Required before prescribing to women of childbearing age.
Contraception Mandatory during and 1 week post-treatment.
Monitoring Needed:
- Liver function tests (LFTs)
- Uric acid levels
- Clinical symptom progression

10. Manufacturer & Regulatory Notes

Approved Under: Emergency use in India, Russia, Japan (as Avigan)
Not FDA-Approved for COVID-19 in the USA
Prescription-Only – Self-medication is unsafe.

Key Takeaways

Fabiflu 400mg is an antiviral for early COVID-19 management.
Strictly avoid in pregnancy (risk category: X).
Early initiation (within 72 hours of symptoms) improves outcomes.

Reviews

There are no reviews yet.

Be the first to review “Fabiflu 400mg”

Description
Reviews (0)

1. Product Description

Brand Name: Fabiflu 400mg
Generic Name: Favipiravir
Manufacturer: Glenmark Pharmaceuticals (India)
Dosage Form: Film-coated tablets
Packaging: Blister strips (varies by pack size)
Approval Status: Emergency use authorization for COVID-19 in India

2. Composition

Component	Details
Active Ingredient	Favipiravir 400mg
Inactive Ingredients	Microcrystalline cellulose, Povidone, Croscarmellose sodium, Magnesium stearate, Film coating agents

3. Therapeutic Uses

Primary Indication:

Treatment of mild to moderate COVID-19 in adults (as per emergency approvals)

Mechanism of Action:

Inhibits RNA-dependent RNA polymerase (RdRp), blocking viral replication of SARS-CoV-2 and other RNA viruses.

Recommended For:

Patients with SpO₂ ≥ 94% (not for severe/critical COVID-19)
Early-stage infection (within 3-5 days of symptom onset)

4. Dosage & Administration

Standard COVID-19 Treatment Course:

Day 1 (Loading Dose): 1800mg (4.5 tablets of 400mg) twice daily
Days 2-10 (Maintenance): 800mg (2 tablets of 400mg) twice daily
Total Duration: 10-14 days (or as prescribed)

Administration Guidelines:
✔ Swallow whole with water (do not crush/chew)
✔ Can be taken with or without food
✔ Maintain consistent 12-hour intervals between doses

5. Contraindications

❌ Pregnancy (teratogenic risk – causes fetal abnormalities)
❌ Severe liver/kidney impairment
❌ History of gout or hyperuricemia (may increase uric acid)
❌ Hypersensitivity to favipiravir

6. Side Effects

Common	Less Common	Serious (Seek Medical Help)
Nausea	Diarrhea	Severe liver damage (jaundice)
Headache	Elevated uric acid	Allergic reactions (rash, swelling)
Stomach pain	Increased ALT/AST (LFT abnormalities)	Neuropsychiatric symptoms (hallucinations)

7. Storage Conditions

Temperature: Below 30°C
Humidity: Keep in a dry place
Packaging: Retain in original blister strips until use
Shelf Life: Typically 24 months (check packaging)

Disposal:

Do not flush. Return unused tablets to pharmacies for safe disposal.

8. Drug Interactions

⚠ Pyrazinamide/Theophylline: May alter drug levels
⚠ Repaglinide: Potential hypoglycemia risk
⚠ Alcohol: May worsen liver effects

9. Special Precautions

Pregnancy Test Required before prescribing to women of childbearing age.
Contraception Mandatory during and 1 week post-treatment.
Monitoring Needed:
- Liver function tests (LFTs)
- Uric acid levels
- Clinical symptom progression

10. Manufacturer & Regulatory Notes

Approved Under: Emergency use in India, Russia, Japan (as Avigan)
Not FDA-Approved for COVID-19 in the USA
Prescription-Only – Self-medication is unsafe.

Key Takeaways

Fabiflu 400mg is an antiviral for early COVID-19 management.
Strictly avoid in pregnancy (risk category: X).
Early initiation (within 72 hours of symptoms) improves outcomes.

Reviews

There are no reviews yet.

Be the first to review “Fabiflu 400mg”

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.